---
schema-version: v1.2.9
id: ISO25539-2-2008
title:
- content: Cardiovascular implants
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: title-intro
- content: Endovascular devices
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: title-main
- content: 'Part 2: Vascular stents'
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: title-part
- content: 'Cardiovascular implants - Endovascular devices - Part 2: Vascular stents'
  language:
  - en
  script:
  - Latn
  format: text/plain
  type: main
- content: Implants cardiovasculaires
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: title-intro
- content: Dispositifs endovasculaires
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: title-main
- content: 'Partie 2: Stents vasculaires'
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: title-part
- content: 'Implants cardiovasculaires - Dispositifs endovasculaires - Partie 2: Stents
    vasculaires'
  language:
  - fr
  script:
  - Latn
  format: text/plain
  type: main
link:
- content: https://www.iso.org/standard/35887.html
  type: src
- content: https://www.iso.org/contents/data/standard/03/58/35887.detail.rss
  type: rss
type: standard
docid:
- id: ISO 25539-2:2008
  type: ISO
  primary: true
- id: ISO 25539-2:2008(E)
  type: iso-reference
- id: urn:iso:std:iso:25539:-2:stage-95.99
  type: URN
docnumber: '25539'
date:
- type: published
  value: 2008-09
contributor:
- organization:
    name:
    - content: International Organization for Standardization
    abbreviation:
      content: ISO
    url: www.iso.org
  role:
  - type: publisher
edition:
  content: '1'
revdate: 2008-09
language:
- en
- fr
script:
- Latn
abstract:
- content: |-
    ISO 25539-2:2008 specifies requirements for vascular stents, based upon current medical knowledge. With regard to safety, it gives requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization packaging and information supplied by the manufacturer. It should be considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.
    The scope of ISO 25539-2:2008 includes vascular stents used to treat vascular lesions or stenoses, or other vascular abnormalities. These devices might or might not incorporate surface modifications of the stent such as drug and/or other coatings. Stents covered with materials that significantly modify the permeability of the uncovered stent are within the scope of ISO 25539-1:2003. The stent design might dictate the need to address functional requirements identified in both ISO 25539-1:2003 and ISO 25539-2:2008.
    Delivery systems are included in ISO 25539-2:2008 if they comprise an integral component of the deployment of the vascular stent.
    Some pharmacological aspects of drug eluting stents are addressed in ISO 25539-2:2008, but this document is not comprehensive with respect to the pharmacological evaluation of drug eluting stents.
    With the exception of sterilization, ISO 25539-2:2008 does not address requirements for the evaluation of animal tissue products.
  language:
  - en
  script:
  - Latn
  format: text/plain
- content: |-
    L'ISO 25539-2:2008 spécifie les exigences relatives aux stents vasculaires selon les connaissances médicales actuelles. En ce qui concerne la sécurité, elle donne les exigences relatives aux performances attendues, aux caractéristiques de conception, aux matériaux, à l'évaluation de la conception, à la fabrication, à la stérilisation, à l'emballage et aux informations fournies par le fabricant. Il convient de la considérer comme un complément à l'ISO 14630 qui spécifie les exigences générales relatives aux performances des implants chirurgicaux non actifs.
    Le domaine d'application de l'ISO 25539-2:2008 inclut les stents utilisés dans le traitement des lésions vasculaires ou sténoses, ou d'autres anomalies vasculaires. Ces dispositifs peuvent comprendre ou non, des modifications de surface du stent telles qu'un revêtement renfermant ou non un médicament. Les stents recouverts de matériaux qui modifient sensiblement l'étanchéité du stent nu sont compris dans le domaine d'application de l'ISO 25539-1:2003. La conception des stents peut rendre nécessaire d'analyser les exigences fonctionnelles identifiées à la fois dans l'ISO 25539-1:2003 et dans l'ISO 25539-2:2008.
    Les systèmes d'injection sont inclus dans l'ISO 25539-2:2008 s'ils comprennent un composant intégral du déploiement du stent vasculaire.
    Certains aspects pharmacologiques des stents à élution de médicaments sont traités dans l'ISO 25539-2:2008, mais celle-ci ne détaille pas l'évaluation pharmacologique de ce type de stent.
    À l'exception de la stérilisation, l'ISO 25539-2:2008 ne traite pas les exigences relatives à l'évaluation des produits de tissus animaux.
  language:
  - fr
  script:
  - Latn
  format: text/plain
docstatus:
  stage:
    value: '95'
  substage:
    value: '99'
copyright:
- owner:
  - name:
    - content: ISO
  from: '2008'
relation:
- type: updates
  bibitem:
    id: ISO25539-2-2012
    type: standard
    docid:
    - id: ISO 25539-2:2012
      type: ISO
      primary: true
    date:
    - type: circulated
      value: '2012-12-05'
    formattedref:
      content: ISO 25539-2:2012
      format: text/plain
place:
- Geneva
ext:
  schema-version: v1.0.3
  doctype:
    type: international-standard
  editorialgroup:
    technical_committee:
    - name: Cardiovascular implants and extracorporeal systems
      number: 150
      type: TC
      identifier: ISO/TC 150/SC 2
  ics:
  - code: 11.040.40
    text: Implants for surgery, prosthetics and orthotics
  structuredidentifier:
    project_number: ISO 25539
    part: '2'
    type: ISO
